WT1 and acute myeloid leukemia: WT1 vaccination therapy showed above-average response durations in three out of five AML patients after induction therapy: one patient demonstrated MRD clearance, another patient showed above-average remission duration and the third patient developed a complete clonal switch at relapse following 18 vaccinations.